
Rocket Lab Stock Climbs 75% on Golden Dome Win Potential and Accelerated Launch Cadence
With RKLB shares above $40, national security contracts, two 2025 mission rollouts in under four days, and Europe’s planned defense-spending boost fuel a fresh valuation review | That's TradingNEWS
Accelerated Launch Cadence Signals Commercial Momentum
Rocket Lab’s ability to vault from contract award to pad roll-out in mere days underscores the company’s growing operational prowess. In mid-June, NASDAQ:RKLB announced two separate missions for a confidential commercial customer—one scheduled just four days after the unveiling—marking the fifth and sixth launches of 2025 and pushing the year’s backlog toward 20 flights. With each Electron mission commanding approximately $7.5 million in revenue, this rapid cadence could translate into nearly $150 million of incremental top-line contribution before year-end. The swift turn-around not only demonstrates integration efficiencies across manufacturing, range coordination and launch execution, but also cements Rocket Lab’s reputation among small-sat operators, many of whom pay premiums for speed-to-orbit.
Golden Dome Defense Deal Enhances National Security Profile
The up-to $10 billion, 10-year enterprise agreement with the U.S. Army elevates Rocket Lab’s role in space-based missile defense, a segment now projected to command a $175 billion budget under the “Golden Dome” initiative. Consolidating 75 legacy contracts into a singular award, this pact implies an average quarterly uplift of $250 million to existing government revenues—boosting the $1.3 billion TTM defense run-rate by roughly 19%. Given President Trump’s stated reluctance to engage SpaceX amid personal frictions, Rocket Lab stands uniquely positioned to supply launch services and integrate its Photon satellite buses for early-warning sensors. This high-visibility contract may also pave the way for follow-on awards from NATO’s forthcoming LEO-PNT navigation constellation, where RKLB has already secured launch slots for European member states.
Rapid Revenue Growth vs. Elevated Valuation Multiples
Since June’s report, RKLB shares have soared almost 75%, climbing from the low $25s to trade near $45 apiece—well above the $34 price target set two months ago. Analysts at Citi lifted their 2029 price objective to $50 based on projected EBITDA maturity, yet near-term metrics tell a different story. TTM revenue stands at $484 million, implying a P/S ratio north of 90x, while consensus forecasts peg 2026 sales at $780 million and EBITDA breakeven in 2026, compressing P/S to 57x and EV/EBITDA to 45x. Comparatively, SpaceX trades closer to 25x forward P/S despite a 2025 revenue estimate of $15.5 billion. A proprietary Aerospace Forum model, blending EV/Sales and EV/EBITDA across public peers, yields a 2029 fair value above $55, but only 21% upside from current levels—suggesting limited room before valuation headwinds emerge.
Neutron Rocket Development: Margin for Error Narrows
The upcoming Neutron medium-lift launcher represents RKLB’s gateway to the $2 billion payload class, but its maiden voyage currently slated for 2026 faces technical and regulatory hurdles. Any slip in the certification timeline or performance shortfall could materially dent investor confidence given the stock’s lofty valuations. R&D spend has doubled year-over-year to $150 million in Q2, yet operating leverage only materializes once Neutron enters service. With fiscal 2025 adjusted operating income guidance between $–280 million and $–200 million, the market’s tolerance for cost overruns is perilously thin.
Technical Breakout Highlights Outperformance vs. S&P 500
On a relative basis, RKLB has formed a classic bull-flag pattern against the S&P 500 index since mid-June, breaking above the descending pennant’s upper trendline in late July. Total shareholder return charts (adjusted for the March 2025 1-for-20 reverse split) show RKLB outperforming the S&P by over 60 percentage points year-to-date. Volume during the pennant breakout was 20% above the 30-day average, reinforcing bullish conviction among institutional buyers. Short interest remains elevated at 11%, hinting at a potential short-squeeze dynamic should fundamental catalysts align.